Literature DB >> 12075089

Mapping of tissue tropism determinants in coxsackievirus genomes.

Heli Harvala1, Hannu Kalimo2, Leif Dahllund1, Juhana Santti1, Pamela Hughes3, Timo Hyypiä4,1, Glyn Stanway3.   

Abstract

Genomic regions responsible for the different tissue tropisms of coxsackievirus A9 (CAV9) and coxsackievirus B3 (CBV3) in newborn mice were investigated using recombinant viruses. Infectious cDNA clones of CAV9, a virus known to infect striated muscle, and CBV3, affecting the central nervous system, pancreas, liver, brown fat and striated muscle, were used to generate chimeric viruses. In situ hybridization analysis of different tissues from mice infected with the recombinant viruses, constructed by exchanging the 5' non-coding region (5'NCR), structural and non-structural genes, demonstrated that the pancreo- and liver tropism map predominantly to CBV3 sequences within the capsid genes, evidently due to receptor recognition. Although the major neurotropism determinant in the CBV3 genome was in the capsid region, viruses containing the CAV9 capsid were also able to initiate infection in the central nervous system provided they contained the CBV3 5'NCR. The presence of the 5'NCR of CAV9 clearly enhanced muscle tissue tropism.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12075089     DOI: 10.1099/0022-1317-83-7-1697

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  16 in total

1.  A novel pancreatropic coxsackievirus vector expressing glucagon-like peptide 1 reduces hyperglycemia in streptozotocin-treated mice.

Authors:  Meixia Dan; Janet K Chantler
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

2.  Efficient replication of recombinant Enterovirus B types, carrying different P1 genes in the coxsackievirus B5 replicative backbone.

Authors:  Nina Jonsson; Anna Sävneby; Maria Gullberg; Kim Evertsson; Karin Klingel; A Michael Lindberg
Journal:  Virus Genes       Date:  2015-02-08       Impact factor: 2.332

3.  Molecular determinants of disease in coxsackievirus B1 murine infection.

Authors:  Javier O Cifuente; María F Ferrer; Carolina Jaquenod de Giusti; Wen-Chao Song; Víctor Romanowski; Susan L Hafenstein; Ricardo M Gómez
Journal:  J Med Virol       Date:  2011-09       Impact factor: 2.327

4.  The crystal structure of a coxsackievirus B3-RD variant and a refined 9-angstrom cryo-electron microscopy reconstruction of the virus complexed with decay-accelerating factor (DAF) provide a new footprint of DAF on the virus surface.

Authors:  Joshua D Yoder; Javier O Cifuente; Jieyan Pan; Jeffrey M Bergelson; Susan Hafenstein
Journal:  J Virol       Date:  2012-09-12       Impact factor: 5.103

5.  An aged host promotes the evolution of avirulent coxsackievirus into a virulent strain.

Authors:  Raina T Gay; Sarah Belisle; Melinda A Beck; Simin Nikbin Meydani
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-01       Impact factor: 11.205

6.  Recombination and selection in the evolution of picornaviruses and other Mammalian positive-stranded RNA viruses.

Authors:  Peter Simmonds
Journal:  J Virol       Date:  2006-09-06       Impact factor: 5.103

7.  Frequency and dynamics of recombination within different species of human enteroviruses.

Authors:  Peter Simmonds; Jon Welch
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

8.  Attenuating mutations in coxsackievirus B3 map to a conformational epitope that comprises the puff region of VP2 and the knob of VP3.

Authors:  E Stadnick; M Dan; A Sadeghi; J K Chantler
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

9.  Coxsackievirus B3 and the neonatal CNS: the roles of stem cells, developing neurons, and apoptosis in infection, viral dissemination, and disease.

Authors:  Ralph Feuer; Ignacio Mena; Robb R Pagarigan; Stephanie Harkins; Daniel E Hassett; J Lindsay Whitton
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

10.  Integrin alpha v beta 6 is an RGD-dependent receptor for coxsackievirus A9.

Authors:  Ciğdem H Williams; Tommi Kajander; Timo Hyypiä; Terry Jackson; Dean Sheppard; Glyn Stanway
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.